Safe-Pro USA to Showcase New NIJ 0101.07 Government Certification-Ready High Performance Body Armor Plates & Innovative RAPID Series Ballistic Shield at SHOT Show 2026

(NASDAQ:SPAI), AVENTURA, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) — Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro” or the “Company”), a developer of artificial intelligence (AI)-enabled defense and security solutions, announced today that its Florida based wholly owned ballistics protection unit, Safe-Pro USA LLC (Safe-Pro USA) will be exhibiting at the upcoming SHOT Show 2026 […]

Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones

(NASDAQ:ERAS), Encouraging early clinical activity, including confirmed partial responses in multiple tumor types with different RAS mutations, coupled with promising safety and pharmacokinetics data, observed for ERAS-0015 during dose escalation Initial Phase 1 monotherapy data for ERAS-0015 (potential best-in-class pan-RAS molecular glue) planned for H1 2026 and for ERAS-4001 (potential first-in-class pan-KRAS inhibitor) planned for

Cabaletta Bio Announces 2026 Strategic Priorities

(NASDAQ:CABA), Registrational myositis trial actively enrolling with planned 17-patient cohort and 2027 rese-cel BLA submission – including an outpatient dosing option using a single weight-based dose IND amendment cleared to manufacture rese-cel with the automated, scalable Cellares platform based on multiple successful engineering runs; clinical manufacturing data expected in 1H26 to confirm GMP readiness, including

Netcapital to Tokenize Hydrogen Drilling Assets

(NASDAQ:NCPL),(NASDAQ:NCPLW),(TSX-V:PWH), Signs PureWave Hydrogen as Initial Client BOSTON, MA, Jan. 12, 2026 (GLOBE NEWSWIRE) — Netcapital Inc. (NASDAQ: NCPL, NCPLW), a digital private capital markets ecosystem, today announced that it has engaged its first issuer of tokenized assets. As part of this initiative, Netcapital has commenced work with PureWave Hydrogen Corp. (TSX.V: PWH), a company

Zapata and University of Maryland Collaborate to Advance New Paradigm in Quantum Software

(PinkSheets:ZPTA),(Pinksheets:ZPTA), BOSTON, Jan. 12, 2026 (GLOBE NEWSWIRE) — Zapata Quantum, Inc. (OTC: ZPTA) (“Zapata”, “Zapata Quantum” or the “Company”), a pioneer in quantum computing application and algorithm development, today announced a collaborative research effort with the University of Maryland (UMD), a global leader in quantum computing and quantum information science. The effort will demonstrate a

Hylaine Appoints Former NTT DATA Executive Doug Hautop as President

CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) — Hylaine, a values-first technology consulting firm, today announced that Doug Hautop has joined the company as president, reporting to company Founder and CEO Adam Boitnott. In this new position, Hautop will lead and execute the firm's growth strategy. This executive hire is the latest in a series

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

(NasdaqGM:ADMA), FY 2025 Preliminary Unaudited Total Revenue of Approximately $510-511 Million Meets or Exceeds Prior Guidance Previously Provided FY 2025 Adjusted EBITDA(1) and Adjusted Net Income(2) Guidance Reiterated Year-End 2025 Cash Grew to Approximately $88 Million with an Unaudited Operating Cash Flow Estimate of ~$40 Million in 4Q 2025 2026 Expected to be ADMA's First

Arcutis Highlights 2026 Strategic Priorities and Anticipated Milestones

(NASDAQ:ARQT), Continued strong growth of ZORYVE(R) (roflumilast) in 2026 with full-year net product sales guidance of $455-$470 million Advancement of ZORYVE indication-expansion strategy beginning with ongoing Phase 2 proof-of-concept trials in vitiligo and hidradenitis suppurativa Initiation of clinical development program for ARQ-234 in atopic dermatitis Transition to positive cash flows enables investment to both accelerate

Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results

(NASDAQ:APYX), CLEARWATER, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) — Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion(R) and the AYON Body Contouring System(TM) (AYON), today reported preliminary revenue results for the fourth quarter and full year ended December 31, 2025. Preliminary Fourth Quarter

JFB Construction Holdings Announces Commencement of Vertical Construction at The Preserve at Port Salerno, Fla.

(NASDAQ:JFB), Anticipated Revenues of $12 million in 2026 for Construction on 79-unit Development Lantana, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) — JFB Construction Holdings (Nasdaq: JFB), a construction company focused on commercial, retail, and residential property development, announces that it is commencing vertical construction at The Preserve at Port Salerno, a 79-unit townhome development with

Scroll to Top